AAAAAA

   
Results: 1-18 |
Results: 18
RESULTS OF ALLOGENEIC BONE-MARROW TRANSPLANTS FOR LEUKEMIA USING DONORS OTHER THAN HLA-IDENTICAL SIBLINGS
Authors: SZYDLO R GOLDMAN JM KLEIN JP GALE RP ASH RC BACH FH BRADLEY BA CASPER JT FLOMENBERG N GAJEWSKI JL GLUCKMAN E HENSLEEDOWNEY PJ HOWS JM JACOBSEN N KOLB HJ LOWENBERG B MASAOKA T ROWLINGS PA SONDEL PM VANBEKKUM DW VANROOD JJ VOWELS MR ZHANG MJ HOROWITZ MM
Citation: R. Szydlo et al., RESULTS OF ALLOGENEIC BONE-MARROW TRANSPLANTS FOR LEUKEMIA USING DONORS OTHER THAN HLA-IDENTICAL SIBLINGS, Journal of clinical oncology, 15(5), 1997, pp. 1767-1777
CHEMOTHERAPY VERSUS TRANSPLANTS FOR ACUTE MYELOGENOUS LEUKEMIA IN 2NDREMISSION
Authors: GALE RP HOROWITZ MM REES JKH GRAY RG OKEN MM ESTEY EH KIM KM ZHANG MJ ASH RC ATKINSON K CHAMPLIN RE DICKE KA GAJEWSKI JL GOLDMAN JM HELBIG W HENSLEEDOWNEY PJ HINTERBERGER W JACOBSEN N KEATING A KLEIN JP MARMONT AM PRENTICE HG REIFFERS J RIMM AA ROWLINGS PA SOBOCINSKI KA SPECK B WINGARD JR BORTIN MM
Citation: Rp. Gale et al., CHEMOTHERAPY VERSUS TRANSPLANTS FOR ACUTE MYELOGENOUS LEUKEMIA IN 2NDREMISSION, Leukemia, 10(1), 1996, pp. 13-19
PULMONARY-FUNCTION CHANGES IN LONG-TERM SURVIVORS OF BONE-MARROW TRANSPLANTATION
Authors: GORE EM LAWTON CA ASH RC LIPCHIK RJ
Citation: Em. Gore et al., PULMONARY-FUNCTION CHANGES IN LONG-TERM SURVIVORS OF BONE-MARROW TRANSPLANTATION, International journal of radiation oncology, biology, physics, 36(1), 1996, pp. 67-75
RISK-FACTORS FOR HEPATIC VENOOCCLUSIVE DISEASE FOLLOWING HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTS FOR LEUKEMIA
Authors: ROZMAN C CARRERAS E QIAN C GALE RP BORTIN MM ROWLINGS PA ASH RC CHAMPLIN RE HENSLEEDOWNEY PJ HERZIG RH HINTERBERGER W KLEIN JP PRENTICE HG REIFFERS J ZWAAN FE HOROWITZ MM
Citation: C. Rozman et al., RISK-FACTORS FOR HEPATIC VENOOCCLUSIVE DISEASE FOLLOWING HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTS FOR LEUKEMIA, Bone marrow transplantation, 17(1), 1996, pp. 75-80
IMPACT OF CYTOGENETIC ABNORMALITIES ON OUTCOME OF BONE-MARROW TRANSPLANTS IN ACUTE MYELOGENOUS LEUKEMIA IN FIRST REMISSION
Authors: GALE RP HOROWITZ MM WEINER RS ASH RC ATKINSON K BABU R DICKE KA KLEIN JP LOWENBERG B REIFFERS J RIMM AA ROWLINGS PA SANDBERG AA SOBOCINSKI KA VEUMSTONE J BORTIN MM
Citation: Rp. Gale et al., IMPACT OF CYTOGENETIC ABNORMALITIES ON OUTCOME OF BONE-MARROW TRANSPLANTS IN ACUTE MYELOGENOUS LEUKEMIA IN FIRST REMISSION, Bone marrow transplantation, 16(2), 1995, pp. 203-208
THERAPEUTIC PLASMA-EXCHANGE DOES NOT APPEAR TO BE EFFECTIVE IN THE MANAGEMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA HEMOLYTIC-UREMIC SYNDROME FOLLOWING BONE-MARROW TRANSPLANTATION
Authors: SARODE R MCFARLAND JG FLOMENBERG N CASPER JT COHEN EP DROBYSKI WR ASH RC HOROWITZ MM CAMITTA B LAWTON C GARBRECHT F GOTTSCHALL JL
Citation: R. Sarode et al., THERAPEUTIC PLASMA-EXCHANGE DOES NOT APPEAR TO BE EFFECTIVE IN THE MANAGEMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA HEMOLYTIC-UREMIC SYNDROME FOLLOWING BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 16(2), 1995, pp. 271-275
BONE-MARROW TRANSPLANTATION FOR FANCONI-ANEMIA
Authors: GLUCKMAN E AUERBACH AD HOROWITZ MM SOBOCINSKI KA ASH RC BORTIN MM BUTTURINI A CAMITTA BM CHAMPLIN RE FRIEDRICH W GOOD RA GORDONSMITH EC HARRIS RE KLEIN JP ORTEGA JJ PASQUINI R RAMSAY NKC SPECK B VOWELS MR ZHANG MJ GALE RP
Citation: E. Gluckman et al., BONE-MARROW TRANSPLANTATION FOR FANCONI-ANEMIA, Blood, 86(7), 1995, pp. 2856-2862
INCREASING INCIDENCE OF ADENOVIRUS DISEASE IN BONE-MARROW TRANSPLANT RECIPIENTS
Authors: FLOMENBERG P BABBITT J DROBYSKI WR ASH RC CARRIGAN DR SEDMAK GV MCAULIFFE T CAMITTA B HOROWITZ MH BUNIN N CASPER JT
Citation: P. Flomenberg et al., INCREASING INCIDENCE OF ADENOVIRUS DISEASE IN BONE-MARROW TRANSPLANT RECIPIENTS, The Journal of infectious diseases, 169(4), 1994, pp. 775-781
EFFECT OF T-CELL DEPLETION AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS ON ENGRAFTMENT, RELAPSE, AND DISEASE-FREE SURVIVAL IN UNRELATED MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: DROBYSKI WR ASH RC CASPER JT MCAULIFFE T HOROWITZ MM LAWTON C KEEVER C BAXTERLOWE LA CAMITTA B GARBRECHT F PIETRYGA D HANSEN R CHITAMBAR CR ANDERSON T FLOMENBERG N
Citation: Wr. Drobyski et al., EFFECT OF T-CELL DEPLETION AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS ON ENGRAFTMENT, RELAPSE, AND DISEASE-FREE SURVIVAL IN UNRELATED MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA, Blood, 83(7), 1994, pp. 1980-1987
IDENTICAL-TWIN BONE-MARROW TRANSPLANTS FOR LEUKEMIA
Authors: GALE RP HOROWITZ MM ASH RC CHAMPLIN RE GOLDMAN JM RIMM AA RINGDEN O STONE JAV BORTIN MM
Citation: Rp. Gale et al., IDENTICAL-TWIN BONE-MARROW TRANSPLANTS FOR LEUKEMIA, Annals of internal medicine, 120(8), 1994, pp. 646-652
PULMONARY-FUNCTION CHANGES IN LONG-TERM SURVIVORS OF BONE-MARROW TRANSPLANTATION
Authors: GORE EM LIPCHIK RJ ASH RC LAWTON CA
Citation: Em. Gore et al., PULMONARY-FUNCTION CHANGES IN LONG-TERM SURVIVORS OF BONE-MARROW TRANSPLANTATION, International journal of radiation oncology, biology, physics, 27, 1993, pp. 185-185
MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS - IN-VITRO SHORT-TERM PROLIFERATION CHARACTERISTICS
Authors: CHANG Q AKARD LP ASH RC KARAFFA B ENGLISH DK JANSEN J
Citation: Q. Chang et al., MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS - IN-VITRO SHORT-TERM PROLIFERATION CHARACTERISTICS, Experimental hematology, 21(8), 1993, pp. 1098-1098
IMMUNOMAGNETIC CD8 DEPLETION
Authors: HANKS S MARTIN M AKARD LP ASH RC ENGLISH DK JANSEN J
Citation: S. Hanks et al., IMMUNOMAGNETIC CD8 DEPLETION, Experimental hematology, 21(8), 1993, pp. 1109-1109
FLUORESCENCE IN-SITU HYBRIDIZATION WITH X-CHROMOSOME AND Y-CHROMOSOMEPROBES FOR CYTOGENETIC STUDIES ON BONE-MARROW CELLS AFTER OPPOSITE SEX TRANSPLANTATION
Authors: DEWALD GW SCHAD CR CHRISTENSEN ER LAW ME ZINSMEISTER AR STALBOERGER PG JALAL SM ASH RC JENKINS RB
Citation: Gw. Dewald et al., FLUORESCENCE IN-SITU HYBRIDIZATION WITH X-CHROMOSOME AND Y-CHROMOSOMEPROBES FOR CYTOGENETIC STUDIES ON BONE-MARROW CELLS AFTER OPPOSITE SEX TRANSPLANTATION, Bone marrow transplantation, 12(2), 1993, pp. 149-154
CLINICAL COURSE OF LATE-ONSET BONE-MARROW TRANSPLANT NEPHROPATHY
Authors: COHEN EP LAWTON CA MOULDER JE BECKER CG ASH RC
Citation: Ep. Cohen et al., CLINICAL COURSE OF LATE-ONSET BONE-MARROW TRANSPLANT NEPHROPATHY, Nephron, 64(4), 1993, pp. 626-635
SALVAGE IMMUNOTHERAPY USING DONOR LEUKOCYTE INFUSIONS AS TREATMENT FOR RELAPSED CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - EFFICACY AND TOXICITY OF A DEFINED T-CELL DOSE
Authors: DROBYSKI WR KEEVER CA ROTH MS KOETHE S HANSON G MCFADDEN P GOTTSCHALL JL ASH RC VANTUINEN P HOROWITZ MM FLOMENBERG N
Citation: Wr. Drobyski et al., SALVAGE IMMUNOTHERAPY USING DONOR LEUKOCYTE INFUSIONS AS TREATMENT FOR RELAPSED CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - EFFICACY AND TOXICITY OF A DEFINED T-CELL DOSE, Blood, 82(8), 1993, pp. 2310-2318
CHOICE OF PRETRANSPLANT TREATMENT AND TIMING OF TRANSPLANTS FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE
Authors: GOLDMAN JM SZYDLO R HOROWITZ MM GALE RP ASH RC ATKINSON K DICKE KA GLUCKMAN E HERZIG RH MARMONT A MASAOKA T MCGLAVE PB MESSNER H OREILLY RJ REIFFERS J RIMM AA SPECK B VEUMSTONE JA WINGARD JR ZWAAN FE BORTIN MM
Citation: Jm. Goldman et al., CHOICE OF PRETRANSPLANT TREATMENT AND TIMING OF TRANSPLANTS FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE, Blood, 82(7), 1993, pp. 2235-2238
IMPACT OF T-CELL DEPLETION AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS ON ENGRAFTMENT, RELAPSE AND DISEASE-FREE SURVIVAL IN UNRELATED MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: DROBYSKI WR ASH RC CASPER JT MCAULIFFE T HOROWITZ MM LAWTON C KEEVER C BAXTERLOWE LA CAMITTA B GARBRECHT F PIETRYGA D HANSEN R CHITAMBAR C ANDERSON T FLOMENBERG N
Citation: Wr. Drobyski et al., IMPACT OF T-CELL DEPLETION AS GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS ON ENGRAFTMENT, RELAPSE AND DISEASE-FREE SURVIVAL IN UNRELATED MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA, Blood, 82(10), 1993, pp. 10000423-10000423
Risultati: 1-18 |